Clinical Trials in Nanning, China
Locations / Nanning, China
Delta Trials records 1,153 clinical trials conducted in Nanning, China, making it a notable site of clinical research activity. These trials across 937 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 43 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Nanning has changed over time.
1153
Total Trials
937
Conditions
43
Terminated since 2020
Browse by condition (937 total)
- Non-small cell lung cancer 59 trialsAll Non-small cell lung cancer trials
- Breast cancer 33 trialsAll Breast cancer trials
- Hepatocellular carcinoma 31 trialsAll Hepatocellular carcinoma trials
- Nasopharyngeal carcinoma 29 trialsAll Nasopharyngeal carcinoma trials
- Advanced solid tumor 20 trialsAll Advanced solid tumor trials
- Carcinoma, non-small-cell lung 16 trialsAll Carcinoma, non-small-cell lung trials
- Cervical cancer 14 trialsAll Cervical cancer trials
- Diabetes mellitus, type 2 13 trialsAll Diabetes mellitus, type 2 trials
- Advanced solid tumors 12 trialsAll Advanced solid tumors trials
- Ovarian cancer 11 trialsAll Ovarian cancer trials
- Colorectal cancer 10 trialsAll Colorectal cancer trials
- All Head and neck squamous cell carcinoma trials
- All Pulmonary disease, chronic obstructive trials
- Lupus nephritis 9 trialsAll Lupus nephritis trials
- Metastatic breast cancer 8 trialsAll Metastatic breast cancer trials
- Her2-positive breast cancer 8 trialsAll Her2-positive breast cancer trials
- Small lymphocytic lymphoma 8 trialsAll Small lymphocytic lymphoma trials
- Diffuse large B-cell lymphoma 8 trialsAll Diffuse large B-cell lymphoma trials
- Endometrial cancer 8 trialsAll Endometrial cancer trials
- Beta-thalassemia 8 trialsAll Beta-thalassemia trials